Packaging & Labelling
ABB granted First Intertek SATELLITE Program Laboratory for ETL and ASTA
Intertek, a leading quality solutions provider to industries worldwide, has approved the ABB laboratory in Ratingen, Germany as the first Intertek SATELLITE™ Data Acceptance...
News
Recipharm and CTC launch integrated first in human service
Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch a new service that...
News
Prediction of Type 2 Diabetes may be more effective by Novel Circulating Biomarkers and Pathways
In 2015, 29 million people in the United States had type 2 diabetes, according to the American Diabetes Association. Type 2 diabetes is generally...
Clinical Trials
Successful Industrial GMP Manufacturing of RIBOXXIM, a Novel and Highly Potent Toll-like 3 Ligand for Immunotherapy of Cancer
RIBOXX PHARMACEUTICALS, a biotech company developing Toll-like-receptor (TLR) and RIG-I-like-Receptor (RLR) ligands, and ACCINOV, a pharmaceutical establishment for experimental drug product announced the successful...
News
Ardena launches following Pharmavize and Crystallics merger
A new early-phase contract development and manufacturing organisation (CDMO), Ardena, has launched following the merging of Pharmavize and Crystallics. The two companies came together...
Clinical Trials
Positive Dupilumab Topline Results From Phase 3 Trial In Uncontrolled Persistent Asthma Announced By Regeneron And Sanofi
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the pivotal Phase 3 LIBERTY ASTHMA QUEST study of dupilumab in a broad population of patients with...
Press Releases
Zavante Therapeutics Announce Agreement To Assess ZOLYD™ for Lower Respiratory Tract Infections With NIAID
Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, has signed a Clinical Trial Agreement...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
